Aetna and Partners Sue Pharma Giants Over Alleged Antitrust Violations in Xifaxan Case
On August 5, 2026, Aetna Inc., along with Health Care Service Corp. and Molina Inc., initiated legal action against several pharmaceutical companies, alleging an antitrust conspiracy to delay the release of generic versions of the drug Xifaxan. The lawsuit, filed in Pennsylvania state court in Pittsburgh, centers around allegations that the defendants engaged in illegal…